IGM Historical Valuation

IGMS Stock  USD 10.55  0.24  2.22%   
Some fundamental drivers such as market cap or IGM Biosciences enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze IGM Biosciences valuation indicators such as Enterprise Value of 537 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of IGM Biosciences's future value.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IGM Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy IGM Stock please use our How to Invest in IGM Biosciences guide.

About IGM Valuation Data Analysis

Valuation is the financial process of determining what IGM Biosciences is worth. IGM Biosciences valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. IGM Biosciences valuation ratios help investors to determine whether IGM Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IGM with respect to the benefits of owning IGM Biosciences security.

IGM Biosciences Valuation Data Chart

Market Cap is likely to gain to about 594.6 M in 2024. Enterprise Value is likely to gain to about 537 M in 2024

Enterprise Value

Enterprise Value (or EV) is usually referred to as IGM Biosciences theoretical takeover price. In the event of an acquisition, an acquirer would have to take on IGM Biosciences debt, but would also pocket its cash. Enterprise Value is more accurate representation of IGM Biosciences value than its market capitalization because it takes into account all of IGM Biosciences existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for IGM Stock Analysis

When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.